PRLD — PRELUDE THERAPEUTICS INC

Ownership history in HRT FINANCIAL LP  ·  4 quarters on record

This page tracks every 13F SEC filing in which HRT FINANCIAL LP reported a position in PRELUDE THERAPEUTICS INC (PRLD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2021 Q4)
Avg. % of fund
0.0%
First filed
2021 Q3
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 16,901 -5,274 -23.8% 0.00% $24K $1.44
2023 Q1 REDUCED 22,175 -92,074 -80.6% 0.00% $126K $5.70
2021 Q4 ADDED 114,249 +98,690 +634.3% 0.01% $1.4M $12.45
2021 Q3 INITIATED 15,559 — — 0.00% $486K $31.25
% of Fund (quarterly)    PRLD price (monthly, adj. close)

Other funds also holding PRLD

As of 2025 Q4 — sorted by position size

ORBIMED ADVISORS LLC 3Y 7Y 0.65% BAKER BROS. ADVISORS LP 3Y 7Y 0.17% Kynam Capital Management, LP 3Y 0.15% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 0.07% XTX Topco Ltd 3Y 0.0% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% TWO SIGMA INVESTMENTS, LP 3Y 7Y 0.0% ACADIAN ASSET MANAGEMENT LLC 3Y 7Y 0.0% CALDWELL SUTTER CAPITAL, INC. 3Y 0.0% OMERS ADMINISTRATION Corp 3Y 7Y 0.0%
← Back to HRT FINANCIAL LP Holdings